How many investments has Qbic Fund made?

Qbic Fund has 25 tracked investments.

What stage does Qbic Fund invest at?

Qbic Fund invests at the Pre-Seed, Seed, Series A stages.

What sectors does Qbic Fund focus on?

Qbic Fund focuses on Advanced Manufacturing, AgTech, AI & Machine Learning, Biotech, Cleantech, Climate Tech, Crypto & Web3, Deep Tech, Digital Health, Energy, FoodTech, Hardware, Healthtech, IoT, Medical Devices, Mobility & Transportation, New Materials, Quantum Computing, SaaS, Sector Agnostic, Semiconductors, Space Tech.

Where is Qbic Fund located?

Qbic Fund is headquartered in St-Denijs-Westrem, BE.

Does Qbic Fund lead rounds?

Qbic Fund typically participates in rounds rather than leading them.

Who does Qbic Fund co-invest with?

Qbic Fund most often shares deals with PMV, Capricorn Venture Partners, Kurma Partners, among 14 tracked co-investors.

Qbic Fund

Venture capital

St-Denijs-Westrem · Pre-Seed–Series A · 18 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

Qbic is a seed and early-stage venture capital fund built around an inter-university model. It backs spin-offs and start-ups that valorize research originating at its knowledge partners — partner universities, research institutes and hospitals. Eligible companies are either knowledge-partner spin-offs founded on technological innovations from those institutions, or start-ups with a strong R&D collaboration with a knowledge partner structured through joint development contracts, clinical studies or IP license agreements. The fund concentrates on deep-technology and life-science innovation, aiming to transform scientific breakthroughs into commercially viable, sustainable ventures across areas such as biotech, therapeutics, photonics, energy and other advanced technologies.

Source: firm website, verified Aug 3, 2026.

Stage

Pre-Seed–Series A

St-Denijs-Westrem, BE

Leads rounds

Follows

Instruments

Equity

Founded

2012

AUM

$205.2M

Tracked investments

Team · 18 people

from the firm's website & public directories

Marc Zabeau· Managing Partner Qbic I· Ghent Metropolitan Areain

m•••@qbicfund.bereveal

Martin De Prycker· Managing Partner Qbic I· Ghent Metropolitan Areain

Veteran technology executive who held senior roles at Alcatel-Lucent, served as CEO of Barco and founded silicon photonics startup Caliopa. He joined Qbic I as a managing partner in 2012.

m•••@qbic.bereveal

Cédric Van Nevel· Partner Qbic II & III, Co-founder Qbic III· Ghent Metropolitan Areain

Former BCG strategy consultant with energy-sector management experience at Fluxys who later led Bekaert's venturing activities before joining Qbic. He holds an MSc in Electronics from Ghent.

c•••@qbic.bereveal

Sofie Baeten· Managing Partner Qbic II & III, (Co-)founder Qbic II & III· Ghent Metropolitan Areain

PhD with a long venture capital track record, previously managing partner at Capital-E, Gimv and Baekeland Fonds II. She holds several board/chair positions in portfolio companies and holds degrees from Ghent, Leuven and Vlerick.

s•••@qbic.bereveal

Steven Leuridan· Partner Qbic II & III, Co-founder Qbic IIIin

PhD and CFA Charterholder focused on projects combining engineering and finance, especially medical applications. He co-founded sleep-products startup Equilli and previously worked with a Belgian family office.

s•••@qbic.bereveal

Guy Huylebroeck· Partner Qbic Iin

g•••@qbic.bereveal

Stéphanie Put· Investment Manager

s•••@qbic.bereveal

Delphine Hajaji· Advisory Board Expert· Ghent Metropolitan Areain

Delphine Hajaji is co-founder and CEO of an undisclosed venture and brings over 20 years of experience in health technology, pharmaceuticals, and healthcare commercialization. She has held board positions and served as an advisor to multiple startups and scale-ups, including companies in EU Commission and EIT Health programs. Her background includes leading local and international teams across digital health, marketing strategy, and venture capital.

Dirk Wauters· Advisory Board Expert· Antwerp Metropolitan Areain

Dirk Wauters is a visiting professor of innovation management at KU Leuven and a business angel investor. He has held senior executive positions at Alcatel and Siemens, serving as CEO of Siemens Networks and VRT, Belgium's public service broadcaster, where he directed operational turnarounds and growth initiatives. His background includes founding Silvar-Lisco, KU Leuven's first spin-off, which listed on Nasdaq in 1984, and five years working in Silicon Valley.

Ellen Crabbe· Advisory Board Expert· Ghent, Flemish Region, Belgiumin

Eric Peeters· Advisory Board Expert· Zwevegem, Flemish Region, Belgiumin

Eric Peeters is Division CEO of Bekaert Construction and a member of the company's Group Executive Committee. He has held leadership and P&L responsibility across multiple industries, including chemicals, home and personal care, construction, solar energy, lighting, industrial manufacturing, coatings, electronics, and automotive. Peeters serves as Vice Chair of the American Cleaning Institute, Chairman of the Energy Materials Industrial Research Initiative, a board member of the Global Silicone Council, and an investment committee member at Qbic, a venture capital fund based in Ghent. He has worked professionally in Belgium, the United Kingdom, the United States, and Switzerland.

Johan Brants· Advisory Board Expert· Ghent Metropolitan Areain

Johan Brants is a European, Belgian, and Dutch patent attorney and founding partner of Brantsandpatents, a firm offering intellectual property services including prosecution, litigation, portfolio management, and enforcement advice. The firm maintains offices in Ghent and Brussels and focuses on chemistry, biotechnology, pharmaceutical, and mechanical engineering patent matters. Brants and his firm have been recognized in the IAM Patent Guide's World's Leading Patent Practitioners.

Katleen Vandersmissen· Advisory Board Expert· Antwerp Metropolitan Areain

Katleen Vandersmissen is Managing Partner at HERAN Partners, a venture capital firm focused on European HealthTech. Her background spans industry, management consultancy, and the venture capital and private equity sectors, with experience across life sciences, technology, and recycling and materials. Her areas of expertise include strategic and business planning, execution, negotiations, people management, and coaching.

k•••@heranpartners.comreveal

Pierre Rion· Advisory Board Expert· Thorembais-les-Béguines, Walloon Region, Belgiumin

Sophie Manigart· LP Committee Chair· Ghent Metropolitan Areain

Sara Vandenwijngaert· Chief Scientific Director Qbic II & III· Ghent, Flemish Region, Belgiumin

Life sciences researcher with a PhD in Cardiovascular Medicine who conducted research at Leuven and Harvard Medical School and managed clinical science at Boston's One Brave Idea initiative before joining Qbic.

s•••@qbic.bereveal

Tom Smets· Investment Associate Qbic II & III· Ghent Metropolitan Areain

Life sciences background with interest in biotech and IT, previously worked at Pfizer and J&J and led an audit team at Ordina before joining Qbic.

t•••@qbic.bereveal

Vincent Lenders· Investment Associate Qbic II & III· Antwerp, Flemish Region, Belgiumin

PhD in Biomedical Sciences focused on nanotechnology for biomedical applications, with research experience at imec, Leuven and Harvard.

v•••@qbic.bereveal

What they invest in

from 12 of 25 portfolio companies

Biotech ×7Medical Devices ×7Healthtech ×6Deep Tech ×5AI & Machine Learning ×3Digital Health ×3AgTech ×2Data & Infrastructure ×2

HQs:Belgium×9

Investments · 25 tracked

founders shown can be your intro path

Obulytixobulytix.com in✓ verified

Obulytix develops Precision Lysin Therapeutics, a novel class of engineered biologics designed to target multidrug-resistant Gram-negative bacteria for severe bloodstream and lung infections.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesGhent, BE

Yves Briers(Scientific Founder)in

Co-investorsBoehringer Ingelheim Venture Fund

AILOS

Redefining actuation for next-generation robotics.

Aloxyaloxy.io in

Aloxy develops industrial IoT solutions including sensors, gateways, and middleware for the chemical, oil and gas, and process industries.

Advanced ManufacturingDeep TechEnterprise SoftwareHardwareIoTAntwerp, BE

Maarten WeynGlenn Ergeerts

AmphiStaramphistar.com in

AmphiStar develops biosurfactants through advanced bioprocessing and fermentation for industrial applications including chemicals and consumer goods.

AgTechBiotechCircular EconomyCleantechClimate TechNew MaterialsGhent, BE

Sophie Roelants(Co-founder & COO)Bernd Everaert(Co-founder & Executive Director)Karolien Maes(Co-founder and Head of Bioprocessing and Scale Up)Sofie De Maeseneire(Co-founder and Head of Synthetic Biology)Pierre-Franck Valentin(CEO)Wim Allegaert(CFO)

Co-investorsEuropean Circular Bioeconomy Fund PMV

Animabanimab.com

Animab develops proprietary antibodies that mimic natural intestinal protection mechanisms to safeguard piglets' health during post-weaning, a critical period in livestock production.

AgTechBiotechDeep TechHealthtechGhent, BE

Vikram Virdi(Chief Science Officer & Scientific Co-Founder)Ann DepickerNico CallewaertEric CoxHenri De GreveAlain Wille(CEO)

Co-investorsAgri Investment Fund Seventure Partners PMV V-Bio Ventures

Axithraaxithra.com in 𝕏

Axithra develops a photonics-based device using Raman spectroscopy on a chip to measure the free, active fraction of drugs in patient blood for bedside therapeutic drug monitoring.

Deep TechHealthtechMedical Devices

Co-investorsKurma Partners White Fund imec.xpand Wallonie Entreprendre

Blue Foot

Provides water-intensive industries with technology to reuse water.

Cascadorcascador.health in

Cascador Health provides real-world data analytics and clinical research services to pharmaceutical companies and healthcare organizations, focusing on market access, clinical evidence generation, and therapy adoption in healthcare.

BiotechData & InfrastructureDigital HealthHealthtechMedical Devices

Philip Taillieu(Founder & CEO)

Co-investorsPMV Volta Ventures

CrowdScancrowdscan.be in 𝕏

CrowdScan builds a wireless sensor network using low-energy radio waves to measure and predict crowd density and movement in real time for public transport, city centers, and events.

GovTechHardwareIoT

eyeo

Color-splitting photonics for ultra-compact, high-performance imaging.

Co-investorsInnovation Industries

Flindr

Aims to restore a patient's impaired immune response to cancer.

Flindr Therapeutics

Aims to restore a patient's impaired immune response to cancer.

Co-investorsPMV

Innocensinnocens.be in

Innocens develops an on-premise data platform for hospitals that collects, synchronizes, and annotates high-frequency time-series medical data from clinical devices, designed specifically for neonatal ICU applications.

AI & Machine LearningData & InfrastructureDigital HealthMedical DevicesBrussels, BE

moveUPmoveup.care

moveUP provides digital platforms for healthcare delivery, offering patient engagement programs, healthcare professional collaboration tools, and real-world data collection across specialties including orthopedics, bariatrics, oncology, and cardiology.

Digital HealthHealthtechSaaS

Co-investorsKarista Nina Capital NovaCapital

MRM Healthmrmhealth.com in

MRM Health develops microbiome-based therapeutics using a precision-engineered platform called CORAL®, which designs and manufactures live bacterial consortia to treat diseases caused by microbiome dysbiosis.

BiotechHealthtechMedical DevicesGhent, BE

Co-investorsAthos VIB Korys

Pleevi

AI-driven smart charging solutions optimizing energy use for electric vehicles.

Rainbow Crops

Multiplex genome editing and precision breeding for climate-resilient crops.

Sightera

AI drug discovery platform and therapeutic asset portfolio to accelerate transformative therapies.

Spica Therapeutics

Pioneering macrophage-subset targeted therapies.

Swave

Holographic extended reality display technology.

Tanai Therapeutics

Developing a first-in-class oral therapeutic for obesity.

THERAtRAMEtheratrame.com in

THERAtRAME is a biotech company developing tRNA-targeting therapies for cancer patients, particularly those resistant to current treatments.

AI & Machine LearningBiotechMedical DevicesLiège, BE

Francesca Rapino(CEO)Pierre Close(CSO)

Co-investorsWallonie Entreprendre

Trincetrincebio.com in

Trince is a Ghent University spin-off developing photoporation technology for physical transfection of cells as an alternative to viral vectors and electroporation.

BiotechDeep TechMedical DevicesGent, BE

Philip

Co-investorsNovalis Biotech

VoxelSensorsvoxelsensors.com

Ultra-low power, ultra-low latency 3D perception sensors for extended reality.

Co-investorsCapricorn Venture Partners

Weavely

Helps companies test and validate digital products before launch.

Frequently asked questions

How many investments has Qbic Fund made?: Qbic Fund has 25 tracked investments.
What stage does Qbic Fund invest at?: Qbic Fund invests at the Pre-Seed, Seed, Series A stages.
What sectors does Qbic Fund focus on?: Qbic Fund focuses on Advanced Manufacturing, AgTech, AI & Machine Learning, Biotech, Cleantech, Climate Tech, Crypto & Web3, Deep Tech, Digital Health, Energy, FoodTech, Hardware, Healthtech, IoT, Medical Devices, Mobility & Transportation, New Materials, Quantum Computing, SaaS, Sector Agnostic, Semiconductors, Space Tech.
Where is Qbic Fund located?: Qbic Fund is headquartered in St-Denijs-Westrem, BE.
Does Qbic Fund lead rounds?: Qbic Fund typically participates in rounds rather than leading them.
Who does Qbic Fund co-invest with?: Qbic Fund most often shares deals with PMV, Capricorn Venture Partners, Kurma Partners, among 14 tracked co-investors.

Similar investors

Everywhere Ventures

Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.

$250K

Khosla Ventures

Khosla Ventures is a venture capital firm founded by Vinod Khosla.

$5K – $50M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M

BDC Fund Investments (Fund-of-Funds)

BDC (Business Development Bank of Canada) is a bank supporting Canadian small and medium-sized businesses across all industries and growth stages with financing and advisory services.